Skip to main content
Erschienen in:

10.01.2022

Survivors’ health competence mediates the association between wearable activity tracker use and self-rated health: HINTS analysis

verfasst von: Steven De La Torre, Donna Spruijt-Metz, Albert J. Farias

Erschienen in: Journal of Cancer Survivorship | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Physical activity (PA) plays an important role in achieving positive self-rated health (SRH) among cancer survivors. Wearable activity trackers (WATs) can be effective for self-monitoring and tracking PA. Studies have shown that survivors who use WATs are more likely to engage in more PA. However, few studies have examined the direct and indirect associations between WAT use, PA, and SRH mediated by constructs derived from self-determination theory, perceived health competence, and perceived social relatedness for health.

Methods

Data on survivors were analyzed from National Cancer Institute’s Health Information National Trend Survey (HINTS) Cycle 1–3 (n = 1,421). Path analysis was used to test the total, direct, and indirect associations.

Results

Previous WAT use was directly associated with PA level (standardized beta (SB): 0.07, p = 0.005) and indirectly associated with SRH (SB: 0.04, p = 0.005), mediated by perceived health competence and PA. Perceived health competence was directly associated with SRH (SB: 0.51, p < .0001) and PA (SB: 0.20, p < .0001), and perceived social relatedness for health was not significantly associated with PA (SB: 0.005, p = 0.8) or SRH (SB: 0.02, p = 0.31).

Conclusions

Overall, these results indicate that perceived health competence significantly mediated the associations between WAT use and SRH; however, WAT use was only directly associated with PA and was not mediated.

Implications for Cancer Survivors

These findings support the notion that WATs may play a role in addressing SRH among cancer survivors through fostering perceived health competence by providing real-time feedback, goal setting, and opportunities for self-monitoring.
Literatur
7.
Zurück zum Zitat Mört S, Salanterä S, Matomäki J, Salmi TT, Lähteenmäki PM. Self-reported health-related quality of life of children and adolescent survivors of extracranial childhood malignancies: a Finnish nationwide survey. Qual Life Res. 2011;20(5):787–97. https://doi.org/10.1007/s11136-010-9798-y. [published Online First: Epub Date]|.CrossRefPubMed Mört S, Salanterä S, Matomäki J, Salmi TT, Lähteenmäki PM. Self-reported health-related quality of life of children and adolescent survivors of extracranial childhood malignancies: a Finnish nationwide survey. Qual Life Res. 2011;20(5):787–97. https://​doi.​org/​10.​1007/​s11136-010-9798-y. [published Online First: Epub Date]|.CrossRefPubMed
13.
15.
Zurück zum Zitat Ndjavera W, Orange ST, O’Doherty AF, et al. Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial. BJU Int. 2020;125(1):28–37. https://doi.org/10.1111/bju.14922. [published Online First: Epub Date]|.CrossRefPubMed Ndjavera W, Orange ST, O’Doherty AF, et al. Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial. BJU Int. 2020;125(1):28–37. https://​doi.​org/​10.​1111/​bju.​14922. [published Online First: Epub Date]|.CrossRefPubMed
27.
Zurück zum Zitat Ryan R, Deci E. Overview of self-determination theory: An organismic-dialectical perspective. Handbook of self-determination research: University of Rochester Press; 2002. p. 3–33. Ryan R, Deci E. Overview of self-determination theory: An organismic-dialectical perspective. Handbook of self-determination research: University of Rochester Press; 2002. p. 3–33.
30.
34.
Zurück zum Zitat De La Torre S, Spruijt-Metz D, Farias AJ. Associations Among Wearable Activity Tracker Use, Exercise Motivation, and Physical Activity in a Cohort of Cancer Survivors: Secondary Data Analysis of the Health Information National Trends Survey. JMIR Cancer. 2021;7(2):e24828. https://doi.org/10.2196/24828. [published Online First: Epub Date]|.CrossRef De La Torre S, Spruijt-Metz D, Farias AJ. Associations Among Wearable Activity Tracker Use, Exercise Motivation, and Physical Activity in a Cohort of Cancer Survivors: Secondary Data Analysis of the Health Information National Trends Survey. JMIR Cancer. 2021;7(2):e24828. https://​doi.​org/​10.​2196/​24828. [published Online First: Epub Date]|.CrossRef
36.
Zurück zum Zitat Step your way through Path Analysis; 2008. Step your way through Path Analysis; 2008.
39.
45.
Metadaten
Titel
Survivors’ health competence mediates the association between wearable activity tracker use and self-rated health: HINTS analysis
verfasst von
Steven De La Torre
Donna Spruijt-Metz
Albert J. Farias
Publikationsdatum
10.01.2022
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 6/2022
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01112-9

Neu im Fachgebiet Onkologie

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.